2 ms·
so much for this earlier article https://news.ycombinator.com/item?id=40400052 https://news.ycombinator.com/item?id=40400052 Lilly last year had to limit shipm
by paulpauper 2y ago
so much for this earlier article https://news.ycombinator.com/item?id=40400052 https://news.ycombinator.com/item?id=40400052
Lilly last year had to limit shipments of Mounjaro in Japan, where it’s approved for treating diabetes, amid a supply crunch. The medicine was also approved for weight loss last year in the US under the brand name Zepbound. A steady ramp up of manufacturing capacity, with investments totaling $18 billion since 2020, is starting to ease the constraint, Simone Thomsen, the company’s Japan president told Bloomberg TV on Thursday.
Just more fake news. The actual reason is not due to Japan's culture, walking, indefatigable willpower, or shaming--but more mundane reasons like Eli Lilly not actually shipping the drug to Japan. I guess that makes sense, or in invoking Occam's Razor, is a more parsimonious explanation instead of having to invent an entire cultural narrative to account for Japan not using the drug. I too was duped by Johann Hari, which does not give me much confidence in any of his other work or of Time Magazine for publishing this fake news. This is why you have to always be skeptical of narratives.